1. Home
  2. IMMP vs ANNA Comparison

IMMP vs ANNA Comparison

Compare IMMP & ANNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • ANNA
  • Stock Information
  • Founded
  • IMMP 1987
  • ANNA 2007
  • Country
  • IMMP Australia
  • ANNA United States
  • Employees
  • IMMP N/A
  • ANNA N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • ANNA
  • Sector
  • IMMP Health Care
  • ANNA
  • Exchange
  • IMMP Nasdaq
  • ANNA NYSE
  • Market Cap
  • IMMP 211.1M
  • ANNA 230.0M
  • IPO Year
  • IMMP N/A
  • ANNA N/A
  • Fundamental
  • Price
  • IMMP $1.50
  • ANNA $13.00
  • Analyst Decision
  • IMMP Buy
  • ANNA
  • Analyst Count
  • IMMP 2
  • ANNA 0
  • Target Price
  • IMMP $8.50
  • ANNA N/A
  • AVG Volume (30 Days)
  • IMMP 84.6K
  • ANNA 18.4K
  • Earning Date
  • IMMP 05-02-2025
  • ANNA 05-15-2025
  • Dividend Yield
  • IMMP N/A
  • ANNA N/A
  • EPS Growth
  • IMMP N/A
  • ANNA N/A
  • EPS
  • IMMP N/A
  • ANNA N/A
  • Revenue
  • IMMP $3,019,249.00
  • ANNA $1,420,030.00
  • Revenue This Year
  • IMMP N/A
  • ANNA N/A
  • Revenue Next Year
  • IMMP $20.28
  • ANNA N/A
  • P/E Ratio
  • IMMP N/A
  • ANNA N/A
  • Revenue Growth
  • IMMP 24.11
  • ANNA N/A
  • 52 Week Low
  • IMMP $1.32
  • ANNA $4.71
  • 52 Week High
  • IMMP $3.34
  • ANNA $18.70
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 39.93
  • ANNA N/A
  • Support Level
  • IMMP $1.44
  • ANNA N/A
  • Resistance Level
  • IMMP $1.56
  • ANNA N/A
  • Average True Range (ATR)
  • IMMP 0.12
  • ANNA 0.00
  • MACD
  • IMMP 0.00
  • ANNA 0.00
  • Stochastic Oscillator
  • IMMP 41.63
  • ANNA 0.00

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About ANNA ALEANNA INC

AleAnna Inc is a developer and producer of natural gas in Italy, engaged in naturally occurring biogenic methane from conventional geological formations and carbon-negative renewable biomethane generated from farm wastes, particularly in the Po Valley of Northern Italy.

Share on Social Networks: